Home » Topics » BioWorld Science

BioWorld Science
RSS

Serum endocan as biomarker to predict postablation recurrence of HCC

Nov. 4, 2019

CTLA-4 plus PD-1 equals more than the sum of its parts

Nov. 4, 2019

Millennium Pharmaceuticals initiates phase I/II study of TAK-981 plus rituximab in NHL

Oct. 31, 2019

First biologic treatment approved for children with lupus in Europe

Oct. 31, 2019

ACADIA Pharmaceuticals initiates phase III LAVENDER study of trofinetide in Rett syndrome

Oct. 31, 2019

New JAK-2 inhibitors identified at East China University of Science and Technology

Oct. 31, 2019

GlaxoSmithKline Biologicals presents new Toll-like receptor 7/8 agonists

Oct. 31, 2019

FDA approves Vumerity for the treatment of multiple sclerosis

Oct. 31, 2019

First patient dosed in phase II study of novel hepcidin mimetic PTG-300

Oct. 31, 2019

Shandong Luoxin Pharmacy Group and Luoxin Pharmaceutical (Shanghai) patent TLR7 agonists

Oct. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...